Immunovant (IMVT)
Immunovant (IMVT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- IMVT last traded at $31.51 on 2026-11-20, -3.11% for the session.
- Immunovant: market cap $6.52B, next earnings 2027-02-05.
- Over the past year IMVT returned 36.05%, with a year-to-date return of 23.96%.